News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
402,447 Results
Type
Article (19103)
Company Profile (119)
Press Release (383223)
Multimedia
Podcasts (45)
Webinars (11)
Section
Business (121454)
Career Advice (795)
Deals (27866)
Drug Delivery (42)
Drug Development (43654)
Employer Resources (61)
FDA (7986)
Job Trends (8595)
News (201216)
Policy (14988)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (1)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (989)
Accelerated approval (30)
ADA (19)
Adcomms (18)
Allergies (60)
Alliances (28000)
ALS (106)
Alzheimer's disease (646)
Antibody-drug conjugate (ADC) (461)
Approvals (8394)
Artificial intelligence (474)
ASCO (336)
Autoimmune disease (198)
Automation (26)
Bankruptcy (192)
Best Places to Work (6834)
BIOSECURE Act (4)
Biosimilars (149)
Biotechnology (99)
Bladder cancer (168)
Brain cancer (65)
Breast cancer (660)
Cancer (5135)
Cardiovascular disease (209)
Career advice (689)
Career pathing (14)
CAR-T (247)
CDC (14)
Celiac Disease (1)
Cell therapy (574)
Cervical cancer (38)
Clinical research (39336)
Collaboration (1438)
Company closure (3)
Compensation (656)
Complete response letters (39)
COVID-19 (975)
CRISPR (59)
C-suite (826)
Cystic fibrosis (52)
Data (5175)
Decentralized trials (1)
Denatured (5)
Depression (63)
Dermatology (48)
Diabetes (284)
Diagnostics (4034)
Digital health (35)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (220)
Drug pricing (63)
Drug shortages (5)
Duchenne muscular dystrophy (105)
Earnings (56450)
Editorial (28)
Employer branding (11)
Employer resources (61)
Events (64766)
Executive appointments (775)
FDA (10244)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (20)
Funding (986)
Gene editing (112)
Generative AI (38)
Gene therapy (321)
GLP-1 (517)
Government (1490)
Grass and pollen (1)
Guidances (329)
Healthcare (10297)
Hematology (142)
HIV (52)
Huntington's disease (14)
IgA nephropathy (51)
Immunology and inflammation (157)
Immuno-oncology (108)
Indications (136)
Infectious disease (1120)
Inflammatory bowel disease (110)
Inflation Reduction Act (7)
Influenza (57)
Intellectual property (166)
Interviews (115)
IPO (10907)
IRA (17)
Job creations (2021)
Job search strategy (593)
JPM (40)
Kidney cancer (22)
Labor market (31)
Layoffs (320)
Leadership (17)
Legal (3808)
Liver cancer (77)
Longevity (14)
Lung cancer (720)
Lymphoma (340)
Machine learning (36)
Management (19)
Manufacturing (564)
MASH (101)
Medical device (6538)
Medtech (6598)
Mergers & acquisitions (18082)
Metabolic disorders (722)
mRNA (132)
Multiple sclerosis (78)
NASH (8)
Neurodegenerative disease (176)
Neuropsychiatric disorders (46)
Neuroscience (1359)
NextGen: Class of 2026 (3279)
Non-profit (1775)
Now hiring (31)
Obesity (321)
Opinion (142)
Ovarian cancer (199)
Pain (99)
Pancreatic cancer (268)
Parkinson's disease (160)
Partnered (14)
Patents (300)
Patient recruitment (387)
Peanut (17)
People (37789)
Pharmaceutical (28)
Pharmacy benefit managers (11)
Phase 1 (12911)
Phase 2 (16787)
Phase 3 (13376)
Pipeline (6309)
Policy (99)
Postmarket research (1269)
Preclinical (4746)
Press Release (68)
Prostate cancer (258)
Psychedelics (16)
Radiopharmaceuticals (276)
Rare diseases (572)
Real estate (3068)
Recruiting (21)
Regulatory (12659)
Reports (30)
Research institute (1247)
Resumes & cover letters (126)
Rett syndrome (34)
RNA editing (8)
RSV (30)
Schizophrenia (116)
Series A (181)
Series B (124)
Service/supplier (3)
Sickle cell disease (67)
Special edition (11)
Spinal muscular atrophy (81)
Sponsored (19)
Startups (2088)
State (2)
Stomach cancer (13)
Supply chain (51)
Tariffs (27)
The Weekly (39)
Vaccines (479)
Venture capital (68)
Weight loss (196)
Women's health (48)
Worklife (3)
Date
Today (66)
Last 7 days (352)
Last 30 days (1984)
Last 365 days (18835)
2026 (9025)
2025 (18932)
2024 (21374)
2023 (24144)
2022 (32535)
2021 (33966)
2020 (31050)
2019 (24644)
2018 (19094)
2017 (18739)
2016 (17199)
2015 (20751)
2014 (15632)
2013 (12423)
2012 (13264)
2011 (13829)
2010 (13220)
Location
Africa (374)
Alabama (38)
Alaska (4)
Arizona (146)
Arkansas (7)
Asia (24527)
Australia (3509)
California (8199)
Canada (2327)
China (994)
Colorado (303)
Connecticut (372)
Delaware (351)
Europe (52768)
Florida (1252)
Georgia (169)
Hawaii (1)
Idaho (35)
Illinois (670)
India (65)
Indiana (364)
Iowa (14)
Japan (441)
Kansas (56)
Kentucky (30)
Louisiana (24)
Maine (68)
Maryland (878)
Massachusetts (6106)
Michigan (175)
Minnesota (353)
Mississippi (1)
Missouri (79)
Montana (25)
Nebraska (15)
Nevada (84)
New Hampshire (42)
New Jersey (2422)
New Mexico (15)
New York (2105)
North Carolina (1012)
North Dakota (7)
Northern California (4321)
Ohio (256)
Oklahoma (7)
Oregon (14)
Pennsylvania (1530)
Puerto Rico (13)
Rhode Island (28)
South America (560)
South Carolina (40)
Southern California (3137)
Tennessee (161)
Texas (1253)
United States (28821)
Utah (240)
Vermont (1)
Virginia (188)
Washington D.C. (41)
Washington State (673)
West Virginia (2)
Wisconsin (102)
Wyoming (1)
402,447 Results for "abraxis oncology acquired by celgene corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
June 8, 2026
·
5 min read
Press Releases
Danaher To Acquire Masimo Corporation
February 17, 2026
·
15 min read
Press Releases
Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
June 2, 2026
·
17 min read
Press Releases
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 8, 2026
·
13 min read
Press Releases
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
January 7, 2026
·
8 min read
Drug Development
Is Revolution ‘the next oncology titan’? Truist analysts make the case
A month after reporting that its RAS inhibitor daraxonrasib doubled survival in advanced pancreatic cancer, Truist said Revolution Medicines “is evolving into a major revenue-generating oncology company,” and projects an approval in second-line disease by the end of the third quarter.
May 18, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
April 7, 2026
·
8 min read
Press Releases
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
December 8, 2025
·
6 min read
Press Releases
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
May 18, 2026
·
5 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation
January 12, 2026
·
7 min read
1 of 40,245
Next
